Healthcare -
Biotechnology - NASDAQ - US
$ 2.28
-3.8 %
$ 60.5 M
Market Cap
-2.13
P/E
GANX - CASH & EQUIVALENTS
Cash & Equivalents GANX - Gain Therapeutics, Inc.
11.8 M
LAST VALUE
-43.45%
2 YEAR CAGR
96.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR